Alain Veilleux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alain Veilleux has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Vincenzo Di Marzo
Université Laval
15 shared publications - André Tchernof
School of Nutrition, Université Laval, Quebec City, Quebec, Canada
9 shared publications - Nicolas Flamand
Centre de recherche de l’Institut universitaire de cardiologie et pneumologie de Québec (IUCPQ), Département de Médecine, Faculté de Médecine, Université Laval
8 shared publications Cyril Martin
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome mediators Axis in Metabolic Health (CERC-MEND), Université Laval
7 shared publicationsNicolas Flamand
Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Québec, Canada
6 shared publicationsAndré Tchernof
Institute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada
5 shared publications
Latest Publications
- Open Access
- 15 June 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Longitudinal changes in endocannabinoidome and dietary lipid profile in severe obesity: impact of sleeve gastrectomy
The endocannabinoid system and its extension, the endocannabinoidome (eCBome), are lipid-based signalling systems involved in regulating energy balance and metabolic homoeostasis. The eCBome includes a variety of bioactive lipids derived from fatty acids, such as N-acylethanolamines (NAEs) and 2-monoacyl-glycerols (2‑MAGs), which have been linked to different patterns of adiposity. Dietary intake, particularly fatty acid intake, plays a key role in shaping the circulating eCBome profile. Bariatric surgery and subsequent diet modifications can significantly modulate the eCBome, potentially restoring metabolic balance in individuals with obesity. The aim of the study is to identify longitudinal changes in the circulating profile of eCBome mediators in individuals living with severe obesity, before and after a sleeve gastrectomy, and to relate these changes to metabolic improvements and changes in dietary intake. The cohort includes 33 adults with severe obesity (BMI ≥ 35 kg/m²), awaiting a sleeve gastrectomy. Blood samples, anthropometric measurements, metabolic profile and dietary intakes (assessed via 24 h dietary recalls) were collected before and 4 months after surgery. Circulating eCBome mediators were quantified by liquid-chromatography tandem mass spectrometry in fasting plasma samples. Four months after sleeve gastrectomy, reductions in adiposity (BMI, body fat mass, waist and neck circumferences) and improvements in metabolic parameters (triglycerides, high-density lipoprotein cholesterol levels and fasting insulin) were accompanied by significant changes in the levels of some circulating eCBome mediators. Post-surgery circulating levels of EPEA and DHEA reduced, whereas levels of 2-AG, 2-LG, 2-DPG and 2-DHG increased after adjusting for pre-surgery levels and sex (P < 0.05). Interestingly, the circulating levels of eCBome mediators within each family (i.e., NAEs and 2-MAGs) were more closely intercorrelated after surgery than before. Adiposity measurements and dietary fatty acid intakes, such as arachidonic acid and omega-3 fatty acids, were associated with the circulating eCBome profile only after surgery. Weight loss and metabolic profile improvements induced by sleeve gastrectomy correlate with changes in the circulating eCBome profile. In severe obesity, neither adiposity nor dietary fatty acid intake appear to directly influence the circulating eCBome profile. The contribution of these factors, which had been previously observed in individuals with normal weight to moderate obesity, only becomes evident following weight loss.
- 15 June 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Open AccessLongitudinal changes in endocannabinoidome and dietary lipid profile in severe obesity: impact of sleeve gastrectomy
The endocannabinoid system and its extension, the endocannabinoidome (eCBome), are lipid-based signalling systems involved in regulating energy balance and metabolic homoeostasis. The eCBome includes a variety of bioactive lipids derived from fatty acids, such as N-acylethanolamines (NAEs) and 2-monoacyl-glycerols (2‑MAGs), which have been linked to different patterns of adiposity. Dietary intake, particularly fatty acid intake, plays a key role in shaping the circulating eCBome profile. Bariatric surgery and subsequent diet modifications can significantly modulate the eCBome, potentially restoring metabolic balance in individuals with obesity. The aim of the study is to identify longitudinal changes in the circulating profile of eCBome mediators in individuals living with severe obesity, before and after a sleeve gastrectomy, and to relate these changes to metabolic improvements and changes in dietary intake. The cohort includes 33 adults with severe obesity (BMI ≥ 35 kg/m²), awaiting a sleeve gastrectomy. Blood samples, anthropometric measurements, metabolic profile and dietary intakes (assessed via 24 h dietary recalls) were collected before and 4 months after surgery. Circulating eCBome mediators were quantified by liquid-chromatography tandem mass spectrometry in fasting plasma samples. Four months after sleeve gastrectomy, reductions in adiposity (BMI, body fat mass, waist and neck circumferences) and improvements in metabolic parameters (triglycerides, high-density lipoprotein cholesterol levels and fasting insulin) were accompanied by significant changes in the levels of some circulating eCBome mediators. Post-surgery circulating levels of EPEA and DHEA reduced, whereas levels of 2-AG, 2-LG, 2-DPG and 2-DHG increased after adjusting for pre-surgery levels and sex (P < 0.05). Interestingly, the circulating levels of eCBome mediators within each family (i.e., NAEs and 2-MAGs) were more closely intercorrelated after surgery than before. Adiposity measurements and dietary fatty acid intakes, such as arachidonic acid and omega-3 fatty acids, were associated with the circulating eCBome profile only after surgery. Weight loss and metabolic profile improvements induced by sleeve gastrectomy correlate with changes in the circulating eCBome profile. In severe obesity, neither adiposity nor dietary fatty acid intake appear to directly influence the circulating eCBome profile. The contribution of these factors, which had been previously observed in individuals with normal weight to moderate obesity, only becomes evident following weight loss.
- Open Access
Circadian disruption alters hepatic calcium hemostasis, endocannabinoidome and mitochondria through N -docosahexaenoyl ethanolamide-GPR110 signaling
Circadian rhythm disruption is associated with metabolic and inflammatory disorders; however, the mechanisms linking circadian dysfunction to endocannabinoidome (eCBome) signaling and mitochondrial metabolism remain unclear. In our previous in vivo study, constant light exposure altered hepatic eCBome profiles, reduced N -acylethanolamines (NAEs), increased monoacylglycerols (MAGs), and elevated inflammatory cytokines. Here, we investigated the underlying mechanisms using CRISPR/Cas9-generated BMAL1 knockout (KO) HepG2 cells as an in vitro model of circadian alteration. The BMAL1 KO model showed broad lipid remodeling characterized by increased fatty acids, prostaglandins, and MAGs together with reduced NAEs and enhanced lipid accumulation. These changes were accompanied by increased inflammatory signaling and cytokine production. Among the assessed genes, GPR110 was significantly altered in mice exposed to constant light ( in vivo study) and BMAL1 KO model and emerged as a potential mediator linking circadian signaling to mitochondrial function. BMAL1 KO cells also exhibited significantly increased calcium (Ca² + ) levels in mitochondria and the endoplasmic reticulum (ER), along with attenuation of mitochondrial and glycolytic ATP production. BMAL1KO did not abolish the rhythmicity of NAEs level over 24 hours from medium deprivation and read ministration except for N -docosahexaenoyl-ethanolamide (DHEA). Further, experiments showed that DHEA acts through GPR110 and suppress inflammatory lipid-associated pathways, enhances ATP production, and increases mitochondrial and ER Ca² + accumulation and inflammatory signaling. Together, these mitochondrial Ca² + signaling, and inflammation in hepatocytes, highlighting DHEA-GPR110 signaling as a potential regulator of hepatic metabolic homeostasis. Highlights: Circadian disruption increases hepatic monoacylglycerols and decreases N -acylethanolamines. Circadian disruption decreases ATP production and enhances mitochondrial and endoplasmic reticulum Ca² + levels in hepatocytes DHEA-GPR110 signaling regulates hepatocytes mitochondrial Ca² + dynamics and ATP production GPR110-mediated Ca² + signaling significantly alters hepatocytes glycolysis and glycolytic ATP production
Open AccessCircadian disruption alters hepatic calcium hemostasis, endocannabinoidome and mitochondria through N -docosahexaenoyl ethanolamide-GPR110 signaling
Circadian rhythm disruption is associated with metabolic and inflammatory disorders; however, the mechanisms linking circadian dysfunction to endocannabinoidome (eCBome) signaling and mitochondrial metabolism remain unclear. In our previous in vivo study, constant light exposure altered hepatic eCBome profiles, reduced N -acylethanolamines (NAEs), increased monoacylglycerols (MAGs), and elevated inflammatory cytokines. Here, we investigated the underlying mechanisms using CRISPR/Cas9-generated BMAL1 knockout (KO) HepG2 cells as an in vitro model of circadian alteration. The BMAL1 KO model showed broad lipid remodeling characterized by increased fatty acids, prostaglandins, and MAGs together with reduced NAEs and enhanced lipid accumulation. These changes were accompanied by increased inflammatory signaling and cytokine production. Among the assessed genes, GPR110 was significantly altered in mice exposed to constant light ( in vivo study) and BMAL1 KO model and emerged as a potential mediator linking circadian signaling to mitochondrial function. BMAL1 KO cells also exhibited significantly increased calcium (Ca² + ) levels in mitochondria and the endoplasmic reticulum (ER), along with attenuation of mitochondrial and glycolytic ATP production. BMAL1KO did not abolish the rhythmicity of NAEs level over 24 hours from medium deprivation and read ministration except for N -docosahexaenoyl-ethanolamide (DHEA). Further, experiments showed that DHEA acts through GPR110 and suppress inflammatory lipid-associated pathways, enhances ATP production, and increases mitochondrial and ER Ca² + accumulation and inflammatory signaling. Together, these mitochondrial Ca² + signaling, and inflammation in hepatocytes, highlighting DHEA-GPR110 signaling as a potential regulator of hepatic metabolic homeostasis. Highlights: Circadian disruption increases hepatic monoacylglycerols and decreases N -acylethanolamines. Circadian disruption decreases ATP production and enhances mitochondrial and endoplasmic reticulum Ca² + levels in hepatocytes DHEA-GPR110 signaling regulates hepatocytes mitochondrial Ca² + dynamics and ATP production GPR110-mediated Ca² + signaling significantly alters hepatocytes glycolysis and glycolytic ATP production
- 1 August 2025
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 329 (2) , G245-G260
Lactiplantibacillus plantarum strengthens the intestinal barrier: involvement of the endocannabinoidome
Lactiplantibacillus plantarum strains improve transepithelial permeability and concomitantly increase the levels of eCBome mediators in murine small intestine epithelial organoids. Pharmacological elevation of NAE or 2-MAG levels enhances the expression of intestinal epithelial barrier genes and reduces the transepithelial permeability of murine small intestine epithelial organoids, suggesting that L. plantarum may exploit eCBome signaling to exert its beneficial effects.
- 1 August 2025
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 329 (2) , G245-G260
Lactiplantibacillus plantarum strengthens the intestinal barrier: involvement of the endocannabinoidome
Lactiplantibacillus plantarum strains improve transepithelial permeability and concomitantly increase the levels of eCBome mediators in murine small intestine epithelial organoids. Pharmacological elevation of NAE or 2-MAG levels enhances the expression of intestinal epithelial barrier genes and reduces the transepithelial permeability of murine small intestine epithelial organoids, suggesting that L. plantarum may exploit eCBome signaling to exert its beneficial effects.
- Open Access
- 26 June 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (13) , e70763
Dietary Manganese Modulates Microbiota and Intestinal N ‐Acylethanolamines in a Sex‐Specific Manner in Mice With Diet‐Induced Obesity
Obesity is characterized by low‐grade inflammation, changes in gut microbiota, and increased tone of the expanded endocannabinoid system (eCBome). The gut is a complex ecosystem that serves as an interface between the diet and its ultimate conversion to nutrients and energy for all cells of the organism. Manganese (Mn) is an essential micronutrient from the diet required for normal cell function and physiological processes. Moreover, it is an indispensable trace mineral for some microbial species since it is a cofactor in several metabolic enzymes. Therefore, we aimed to identify possible interactions between gut microbiota composition and the eCBome during dietary variations of Mn in the context of diet‐induced obesity. Female and male mice were fed Mn‐depleted and Mn‐enriched diets in combination with Low Fat‐Low Sucrose (LFLS) or High Fat‐High Sucrose (HFHS) diets for 28 days to assess intestinal microbiota and eCBome levels. Mn‐enriched diets enhanced the circulating levels of N ‐docosapentaenoyl‐ethanolamine (DPEA) and anandamide (AEA), while they reduced the intestinal concentrations of other N ‐acylethanolamines, particularly in the caecum. Besides, we found a strong sex effect of Mn on the intestinal levels of 2‐monoacylglycerols (2‐MAGs), which were lower in females. Other endocannabinoid‐like molecules involved in the immune response were impacted by dietary Mn enrichment, such as N ‐palmitoyl‐glycine and N ‐oleoyl‐L‐serine. Concomitantly, Mn enrichment promoted segment‐specific changes in the relative abundance of several taxa in intestinal microbiota following the HFHS diet. Microbial families such as Peptostreptococcaceae , Muribaculaceae , and Erysipelotrichaceae responded differentially to dietary variations in Mn. This study hints at potential interactions between Mn levels and diet composition with the eCBome and intestinal bacteria during dietary Mn variations within HFHS‐induced dysmetabolic processes in a sex‐dependent manner. These results will eventually contribute to identifying members of the gut microbiome and mediators of the eCBome useful for improving metabolic health.
- 26 June 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (13) , e70763
Open AccessDietary Manganese Modulates Microbiota and Intestinal N ‐Acylethanolamines in a Sex‐Specific Manner in Mice With Diet‐Induced Obesity
Obesity is characterized by low‐grade inflammation, changes in gut microbiota, and increased tone of the expanded endocannabinoid system (eCBome). The gut is a complex ecosystem that serves as an interface between the diet and its ultimate conversion to nutrients and energy for all cells of the organism. Manganese (Mn) is an essential micronutrient from the diet required for normal cell function and physiological processes. Moreover, it is an indispensable trace mineral for some microbial species since it is a cofactor in several metabolic enzymes. Therefore, we aimed to identify possible interactions between gut microbiota composition and the eCBome during dietary variations of Mn in the context of diet‐induced obesity. Female and male mice were fed Mn‐depleted and Mn‐enriched diets in combination with Low Fat‐Low Sucrose (LFLS) or High Fat‐High Sucrose (HFHS) diets for 28 days to assess intestinal microbiota and eCBome levels. Mn‐enriched diets enhanced the circulating levels of N ‐docosapentaenoyl‐ethanolamine (DPEA) and anandamide (AEA), while they reduced the intestinal concentrations of other N ‐acylethanolamines, particularly in the caecum. Besides, we found a strong sex effect of Mn on the intestinal levels of 2‐monoacylglycerols (2‐MAGs), which were lower in females. Other endocannabinoid‐like molecules involved in the immune response were impacted by dietary Mn enrichment, such as N ‐palmitoyl‐glycine and N ‐oleoyl‐L‐serine. Concomitantly, Mn enrichment promoted segment‐specific changes in the relative abundance of several taxa in intestinal microbiota following the HFHS diet. Microbial families such as Peptostreptococcaceae , Muribaculaceae , and Erysipelotrichaceae responded differentially to dietary variations in Mn. This study hints at potential interactions between Mn levels and diet composition with the eCBome and intestinal bacteria during dietary Mn variations within HFHS‐induced dysmetabolic processes in a sex‐dependent manner. These results will eventually contribute to identifying members of the gut microbiome and mediators of the eCBome useful for improving metabolic health.
- Open Access
- 7 April 2025
- Published by Open Exploration Publishing
- Vol. 2, 101427
Circulating endocannabinoids and brain anatomy: unraveling the weight loss connection through lifestyle and surgery approaches
Obesity is a multifactorial disease linked to many comorbidities and has an impact on brain health. It is also known that obesity disrupts the endocannabinoid (eCB) system in the central nervous system and in the periphery, which complicates the underlying mechanisms behind obesity. However, weight loss through lifestyle interventions or bariatric surgery may alleviate obesity-related comorbidities, as well as restore eCB tone. Several studies have reported a decrease in circulating eCBs following weight loss, likely due to the positive association of these mediators with fat mass. However, further research is needed to clarify whether this reduction is a consequence of weight loss or plays a role in facilitating it. This review explores changes in circulating eCBs following weight loss and their potential roles in cerebral homeostasis and the reward system. It examines how lifestyle modifications and bariatric surgery may influence central eCB signalling and contribute to long-term weight loss success. Understanding the mechanisms behind improved brain function after weight loss could provide insights into optimizing obesity treatments.
- 7 April 2025
- Published by Open Exploration Publishing
- Vol. 2, 101427
Open AccessCirculating endocannabinoids and brain anatomy: unraveling the weight loss connection through lifestyle and surgery approaches
Obesity is a multifactorial disease linked to many comorbidities and has an impact on brain health. It is also known that obesity disrupts the endocannabinoid (eCB) system in the central nervous system and in the periphery, which complicates the underlying mechanisms behind obesity. However, weight loss through lifestyle interventions or bariatric surgery may alleviate obesity-related comorbidities, as well as restore eCB tone. Several studies have reported a decrease in circulating eCBs following weight loss, likely due to the positive association of these mediators with fat mass. However, further research is needed to clarify whether this reduction is a consequence of weight loss or plays a role in facilitating it. This review explores changes in circulating eCBs following weight loss and their potential roles in cerebral homeostasis and the reward system. It examines how lifestyle modifications and bariatric surgery may influence central eCB signalling and contribute to long-term weight loss success. Understanding the mechanisms behind improved brain function after weight loss could provide insights into optimizing obesity treatments.
- Open Access
- 20 March 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2476563
Seasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans
The human gut microbiome-endocannabinoidome axis is crucial for several homeostatic processes, including inflammation and energy metabolism, and is influenced by many endogenous and exogenous factors, such as dietary habits. Changes in the gut microbiome in response to seasonal variations were previously reported and tentatively attributed to shifts in dietary patterns. However, there is a need for longitudinal studies in industrialized populations to comprehensively explore seasonal variations independently of lifestyle confounding factors. To investigate the longitudinal effects of seasonal variations on the composition of the gut microbiome and the circulating levels of endocannabinoidome mediators in humans, while elucidating the contributing factors underlying these changes. Plasma and fecal samples were collected at the end of both the winter and summer in a longitudinal cohort of 48 individuals living in Québec City (Canada). Dietary habits, medical history, fecal microbiota taxonomic composition and plasma levels of circulating N‑acyl‑ethanolamines (NAEs) and 2‑monoacyl-glycerols (2‑MAGs) were obtained at each time point. Lower circulating levels of most NAEs were observed at the end of summer. These changes were accompanied by a reduction in the relative abundance of the Bifidobacteriaceae and Lachnospiraceae families, along with an increase in the abundance of the Bacteroidaceae and Ruminococcaceae families. These seasonal variations were not associated with concurrent changes in adiposity parameters, dietary intakes, physical activity habits, or vitamin D status. Importantly, the magnitude of the shift in gut microbiota composition from winter to summer was found to be associated with the seasonal variations in circulating endocannabinoidome (eCBome) mediators. This study identified specific seasonal changes in gut microbiota composition and circulating levels of several NAEs, which were not associated with vitamin D status and lifestyle habits. It underscores the importance of the gut microbiota-endocannabinoidome axis in the pathophysiology of seasonal changes, and of considering seasons in clinical trials on these systems.
- 20 March 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2476563
Open AccessSeasonal variations in circulating endocannabinoidome mediators and gut microbiota composition in humans
The human gut microbiome-endocannabinoidome axis is crucial for several homeostatic processes, including inflammation and energy metabolism, and is influenced by many endogenous and exogenous factors, such as dietary habits. Changes in the gut microbiome in response to seasonal variations were previously reported and tentatively attributed to shifts in dietary patterns. However, there is a need for longitudinal studies in industrialized populations to comprehensively explore seasonal variations independently of lifestyle confounding factors. To investigate the longitudinal effects of seasonal variations on the composition of the gut microbiome and the circulating levels of endocannabinoidome mediators in humans, while elucidating the contributing factors underlying these changes. Plasma and fecal samples were collected at the end of both the winter and summer in a longitudinal cohort of 48 individuals living in Québec City (Canada). Dietary habits, medical history, fecal microbiota taxonomic composition and plasma levels of circulating N‑acyl‑ethanolamines (NAEs) and 2‑monoacyl-glycerols (2‑MAGs) were obtained at each time point. Lower circulating levels of most NAEs were observed at the end of summer. These changes were accompanied by a reduction in the relative abundance of the Bifidobacteriaceae and Lachnospiraceae families, along with an increase in the abundance of the Bacteroidaceae and Ruminococcaceae families. These seasonal variations were not associated with concurrent changes in adiposity parameters, dietary intakes, physical activity habits, or vitamin D status. Importantly, the magnitude of the shift in gut microbiota composition from winter to summer was found to be associated with the seasonal variations in circulating endocannabinoidome (eCBome) mediators. This study identified specific seasonal changes in gut microbiota composition and circulating levels of several NAEs, which were not associated with vitamin D status and lifestyle habits. It underscores the importance of the gut microbiota-endocannabinoidome axis in the pathophysiology of seasonal changes, and of considering seasons in clinical trials on these systems.
- Open Access
- 22 August 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (3) , 739-747
The Human Fecal Endocannabinoidome Mediator Profile Is Mainly Defined by the Fecal Microbiota and Diet
Background The endocannabinoid system and its extension, the endocannabinoidome (eCBome), are involved in numerous biological processes, notably energy homeostasis, across virtually all tissues. While the circulating eCBome mediator profile is associated with dietary intakes and metabolic status, an important knowledge gap resides in the identification of the precise determinants of these mediators in the gut lumen. We aimed at establishing the profile of eCBome mediators in human feces and investigating their association with circulating eCBome mediators, dietary intakes, metabolic status and gut microbiota composition. Methods N-acyl-ethanolamines (NAEs) and 2-monoacyl-glycerols (2-MAGs) were profiled by LC-MS/MS in plasma and feces of a cross-sectional cohort (n = 195) and a short term dietary intervention trials (n = 21) with comprehensive dietary intakes and gut microbiota measures. Results Six NAEs and seven 2-MAGs were identified in fecal samples, but some, especially omega-3 derived mediators, were undetectable in the majority of samples. Fecal NAEs, and to a lower extent 2-MAGs, were positively albeit weakly correlated with the circulating levels of eCBome mediators. Fecal 2-AG, PEA and DHEA levels were positively associated with visceral adiposity and with some parameters of the metabolic profile. Dietary intakes of foods rich in fibers were associated with lower fecal levels of several eCBome mediators, while intakes of unsaturated fatty acids were associated with fecal 2-OG and 2-LG. Interestingly, gut microbiota diversity and composition were a strong correlate of the fecal eCBome profile. Conclusion The fecal eCBome profile is associated with gut microbiota composition and dietary intakes, more than with the circulating profile. These results strengthen the hypothesis of an interrelation between the gut microbiome and eCBome signaling involved in the regulation of numerous host biological processes.
- 22 August 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (3) , 739-747
Open AccessThe Human Fecal Endocannabinoidome Mediator Profile Is Mainly Defined by the Fecal Microbiota and Diet
Background The endocannabinoid system and its extension, the endocannabinoidome (eCBome), are involved in numerous biological processes, notably energy homeostasis, across virtually all tissues. While the circulating eCBome mediator profile is associated with dietary intakes and metabolic status, an important knowledge gap resides in the identification of the precise determinants of these mediators in the gut lumen. We aimed at establishing the profile of eCBome mediators in human feces and investigating their association with circulating eCBome mediators, dietary intakes, metabolic status and gut microbiota composition. Methods N-acyl-ethanolamines (NAEs) and 2-monoacyl-glycerols (2-MAGs) were profiled by LC-MS/MS in plasma and feces of a cross-sectional cohort (n = 195) and a short term dietary intervention trials (n = 21) with comprehensive dietary intakes and gut microbiota measures. Results Six NAEs and seven 2-MAGs were identified in fecal samples, but some, especially omega-3 derived mediators, were undetectable in the majority of samples. Fecal NAEs, and to a lower extent 2-MAGs, were positively albeit weakly correlated with the circulating levels of eCBome mediators. Fecal 2-AG, PEA and DHEA levels were positively associated with visceral adiposity and with some parameters of the metabolic profile. Dietary intakes of foods rich in fibers were associated with lower fecal levels of several eCBome mediators, while intakes of unsaturated fatty acids were associated with fecal 2-OG and 2-LG. Interestingly, gut microbiota diversity and composition were a strong correlate of the fecal eCBome profile. Conclusion The fecal eCBome profile is associated with gut microbiota composition and dietary intakes, more than with the circulating profile. These results strengthen the hypothesis of an interrelation between the gut microbiome and eCBome signaling involved in the regulation of numerous host biological processes.
- 1 April 2024
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 49 (4) , 428-436
GLP-1 response during pregnancy: variations between trimesters and associations with appetite sensations and usual energy intake
Further research is required to understand hormonal regulation of food intake during pregnancy and its association with energy intake. The objectives are to ( i) compare postprandial responses of plasma glucagon-like peptide-1 (GLP-1) between trimesters, ( ii) compare postprandial appetite sensations between trimesters, and ( iii) examine trimester-specific associations between GLP-1 levels, appetite sensations, and usual energy intake. At each trimester, participants ( n = 26) consumed a standard test meal following a 12 h fast. Plasma GLP-1 levels were measured by enzyme-linked immunosorbent assay method at fasting and at 30, 60, 120, and 180 min postprandial. A visual analogue scale assessing appetite sensations was completed at fasting and at 15, 30, 45, 60, 90, 120, 150, and 180 min postprandial. Mean energy intake was assessed using three web-based 24 h dietary recalls at each trimester. Lower postprandial GLP-1 responses were observed in the 2nd ( p = 0.004) and 3rd trimesters ( p < 0.001) compared to the 1st trimester. Greater postprandial sensations of desire to eat, hunger, and prospective food consumption were noted in the 3rd trimester compared to the 1st trimester ( p < 0.04, for all). Fasting GLP-1 was negatively associated with fasting appetite sensations (except fullness) at the 2nd trimester ( p < 0.02, for all). Postprandially, significant associations were observed for incremental areas under the curve from 0 to 30 min between GLP-1 and fullness at the 2nd ( p = 0.01) and 3rd trimesters ( p = 0.03). No associations between fasting or postprandial GLP-1 and usual energy intake were observed. Overall, GLP-1 and appetite sensation responses significantly differ between trimesters, but few associations were observed between GLP-1, appetite sensations, and usual energy intake.
- 1 April 2024
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 49 (4) , 428-436
GLP-1 response during pregnancy: variations between trimesters and associations with appetite sensations and usual energy intake
Further research is required to understand hormonal regulation of food intake during pregnancy and its association with energy intake. The objectives are to ( i) compare postprandial responses of plasma glucagon-like peptide-1 (GLP-1) between trimesters, ( ii) compare postprandial appetite sensations between trimesters, and ( iii) examine trimester-specific associations between GLP-1 levels, appetite sensations, and usual energy intake. At each trimester, participants ( n = 26) consumed a standard test meal following a 12 h fast. Plasma GLP-1 levels were measured by enzyme-linked immunosorbent assay method at fasting and at 30, 60, 120, and 180 min postprandial. A visual analogue scale assessing appetite sensations was completed at fasting and at 15, 30, 45, 60, 90, 120, 150, and 180 min postprandial. Mean energy intake was assessed using three web-based 24 h dietary recalls at each trimester. Lower postprandial GLP-1 responses were observed in the 2nd ( p = 0.004) and 3rd trimesters ( p < 0.001) compared to the 1st trimester. Greater postprandial sensations of desire to eat, hunger, and prospective food consumption were noted in the 3rd trimester compared to the 1st trimester ( p < 0.04, for all). Fasting GLP-1 was negatively associated with fasting appetite sensations (except fullness) at the 2nd trimester ( p < 0.02, for all). Postprandially, significant associations were observed for incremental areas under the curve from 0 to 30 min between GLP-1 and fullness at the 2nd ( p = 0.01) and 3rd trimesters ( p = 0.03). No associations between fasting or postprandial GLP-1 and usual energy intake were observed. Overall, GLP-1 and appetite sensation responses significantly differ between trimesters, but few associations were observed between GLP-1, appetite sensations, and usual energy intake.
- Open Access
- 21 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Dietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
The gut microbiota and the endocannabinoidome (eCBome) play important roles in regulating energy homeostasis, and both are closely linked to dietary habits. However, the complex and compositional nature of these variables has limited our understanding of their interrelationship. This study aims to decipher the interrelation between dietary intake and the gut microbiome–eCBome axis using two different approaches for measuring dietary intake: one based on whole food and the other on macronutrient intakes. We reveal that food patterns, rather than macronutrient intakes, were associated with the gut microbiome–eCBome axis in a sample of healthy men and women (n = 195).N-acyl-ethanolamines (NAEs) and gut microbial families were correlated with intakes of vegetables, refined grains, olive oil and meats independently of adiposity and energy intakes. Specifically, higher intakes in vegetables and olive oil were associated with increased relative abundance ofClostridiaceae, VeillonellaceaeandPeptostreptococaceae, decreased relative abundance ofAcidominococaceae, higher circulating levels of NAEs, and higher HDL and LDL cholesterol levels. Our findings highlight the relative importance of food patterns in determining the gut microbiome–eCBome axis. They emphasize the importance of recognizing the contribution of dietary habits in these systems to develop personalized dietary interventions for preventing and treating metabolic disorders through this axis.
- 21 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Open AccessDietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
The gut microbiota and the endocannabinoidome (eCBome) play important roles in regulating energy homeostasis, and both are closely linked to dietary habits. However, the complex and compositional nature of these variables has limited our understanding of their interrelationship. This study aims to decipher the interrelation between dietary intake and the gut microbiome–eCBome axis using two different approaches for measuring dietary intake: one based on whole food and the other on macronutrient intakes. We reveal that food patterns, rather than macronutrient intakes, were associated with the gut microbiome–eCBome axis in a sample of healthy men and women (n = 195).N-acyl-ethanolamines (NAEs) and gut microbial families were correlated with intakes of vegetables, refined grains, olive oil and meats independently of adiposity and energy intakes. Specifically, higher intakes in vegetables and olive oil were associated with increased relative abundance ofClostridiaceae, VeillonellaceaeandPeptostreptococaceae, decreased relative abundance ofAcidominococaceae, higher circulating levels of NAEs, and higher HDL and LDL cholesterol levels. Our findings highlight the relative importance of food patterns in determining the gut microbiome–eCBome axis. They emphasize the importance of recognizing the contribution of dietary habits in these systems to develop personalized dietary interventions for preventing and treating metabolic disorders through this axis.